NortonLifeLock's stock to equal-weight, saying the firm sees"limited catalysts" for the cybersecurity company. A regulatory probe in the United Kingdom into NortonLifeLock's $8.6 billion deal with Avast and higher inflation costs is weighing on the stock.
Download NBC 5 Dallas-Fort WorthWe have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: